Pharmacy Discounts May Lead to Hidden Costs for Insured Patients
A recent study published by the Journal of the American Medical Association highlights the complexities surrounding manufacturer-sponsored drug coupons at pharmacy counters. These coupons, often offered to patients with commercial insurance, are designed to reduce out-of-pocket costs for brand-name drugs. However, they may inadvertently lead to higher insurance premiums and out-of-pocket expenses in the long run. The study, led by So-Yeon Kang from Georgetown University, indicates that while manufacturers continue to offer these coupons, their usage among insured patients has declined. This decline is attributed to insurers' reluctance to cover more expensive brand-name drugs when cheaper generics are available. The study also notes that some states, like California and Massachusetts, have restrictions on these coupons when generic alternatives exist. 
